With an increasingly aging population, the need for effective treatment of cardiovascular diseases (eg, heart failure, hypertension, and ischemic heart disease) cannot be overemphasized. The vital importance of mineralocorticoid receptor antagonists for treating cardiovascular conditions has only been appreciated in the last decade. The re-emergence of mineralocorticoid receptor antagonists has provided clinicians with an important tool towards complete blockade of the renin-angiotensin-aldosterone axis.
- SELECTIVE ALDOSTERONE BLOCKER
- LEFT-VENTRICULAR HYPERTROPHY
- RANDOMIZED ALDACTONE EVALUATION